Jacqueline Lane

Assistant Professor

Brigham and Women's Hospital
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Sleep disorders affect over 30% of the U.S population and are linked to increased disease risk and mortality. However, the genetic architecture of sleep disorders and the overlap of sleep disorders with habitual sleep quality, quantity, and timing have been poorly characterized. In addition, it is unknown if clinical sleep disorders are extremes of habitual sleep traits. Here, we systematically investigated the genetic basis of seven clinical sleep disorder traits, and sixteen medications used for sleep problems in 1,600,000 individuals. We identified 590 genetic associations for sleep apnea, insomnia, restless legs syndrome, narcolepsy and a combined sleep disorder phenotype, of which 367 were previously unreported. Additionally, we discovered 142 genetic associations with sleep medication use. While overall genetic architecture was shared across sleep traits, we found unique genetic factors for the different sleep disorders that reflect fundamentally different biological mechanisms including for example autoimmune processes with narcolepsy and skeletal morphology in sleep apnea. Furthermore, sleep genetic factors showed a broad multi-omic impact on gene and protein expression levels. These findings suggest that while clinical sleep disorders share genetic architecture with each other and with variation in sleep patterns within the general population, they are not simply extremes of normal sleep variation but involve unique biological mechanisms. These results advance our understanding of sleep disorders and suggest potential novel therapeutic targets.

Year:

2025

Evening chronotypes (a.k.a. night-owls) are held to be at greater risk for psychiatric disorders. This is postulated to be due to delayed circadian timing increasing the likelihood of circadian misalignment in an early-oriented society. Circadian misalignment is known to heighten sleep inertia, the difficulty transitioning from sleep to wake characterized by low arousal and cognitive impairment, and evening chronotypes experience greater sleep inertia. Therefore, difficulty awakening may explain the relationship between evening chronotype and psychiatric disorders by acting as a biomarker of circadian misalignment. In analyzing the longitudinal incidence of psychiatric disorders in the UK Biobank (n = 496,820), we found that evening chronotype predicted increased incidence of major depressive disorder, schizophrenia, generalized anxiety disorder and bipolar disorder. Crucially, this effect was dependent on sleep inertia, which was a much stronger predictor of these disorders, such that evening types without sleep inertia were at no higher risk as compared to morning types. Longitudinal analyses of suicide and depressed mood (CES-D score) in the Older Finnish Twin Cohort (n = 23,854) replicated this pattern of results. Twin and genome-wide association analyses of difficulty awakening identified the trait to be heritable (Twin H2 = 0.40; SNP h2 = 0.08), enriched for circadian rhythms genes and have substantial shared genetic architecture with chronotype. Marginal and conditional Mendelian randomization analyses mirrored the epidemiological results, such that the causal effect of evening chronotype on psychiatric disorders was driven by shared genetic architecture with difficulty awakening. In contrast, difficult awakening was strongly causally associated with psychiatric disorders independently of chronotype. Psychiatric disorders were only weakly reverse causally linked to difficult awakening. Collectively, these results challenge the notion that evening chronotype is a risk factor for psychiatric disorders per se, suggesting instead that evening types are at greater risk for psychiatric disorders due to circadian misalignment, for which sleep inertia may be acting as a biomarker.

Year:

2024

Objectives: The objective of this review was to evaluate the diagnosis and treatment of advanced and delayed sleep-wake phase disorders (ASWPD, DSWPD), both forms of circadian rhythm sleep-wake disorders (CRSWDs) using both human reviewers and ChatGTP to summarize relevant content. Methods: PubMed-Medline, EbscoHost, and Web of Science were searched for peer reviewed articles. Original research articles published in English were searched for full-text studies. Studies that reported quantitative data on ASWPD and DSWPD diagnosing tools and treatment options in individuals of all ages were assessed. We assessed ChatGTP 4.0s capacity to extract and summarize data from these studies and evaluated it alongside human reviewers. Results: Our review of 49 articles on CRSWD from the past 20 years found that 91% focused on DSWPD. The most common diagnostic tools were the MEQ, MCQ, Pittsburgh Sleep Quality Index, and Epworth Sleepiness Scale, with primary methods including actigraphy and dim-light-melatonin-onset. Melatonin, often combined with light therapy and CBT, was the predominant treatment. ChatGPT-4.0 facilitated the review process with about 92% accuracy but required manual oversight for optimal results. Conclusions: Our review identified key diagnostic tools, such as MEQ and MCQ surveys, and common treatment options for ASWPD and DSWPD, including melatonin, light therapy, and CBT. The findings underscore the need for comprehensive and individualized treatment approaches for CRSWDs, with a particular focus on expanding research on ASWPD and increasing data representation across age groups. While ChatGPT shows potential in streamlining data extraction for CRSWDs, it still requires human oversight to ensure accuracy.

Year:

2024

Collaborators (11)

Hanna Ollila

University of Helsinki

FINLAND
View details

Renato Polimanti

Yale University School of Medicine

UNITED STATES
View details

Tian Ge

Broad Institute

UNITED STATES
View details

Stephanie Zellers

University of Helsinki

FINLAND
View details

Michael N Weedon

Associate Professor

University of Exeter Medical School

UNITED KINGDOM
View details

Nasa Sinnott-Armstrong

Assistant Professor

Fred Hutch Cancer Center

UNITED STATES
View details

Martin Rutter

Professor of Cardiometabolic Medicine

The University of Manchester

UNITED KINGDOM
View details

Andrew Wood

Lecturer in Statistical Genetics and Health Data Science

University of Exeter

UNITED KINGDOM
View details

Richa Saxena

Professor of Anaesthesia

Harvard Medical School

UNITED STATES
View details

Jaakko Kaprio

Research Director

University of Helsinki

FINLAND
View details

Sean Cain

Professor

Flinders University

AUSTRALIA
View details